INVENTIVA (EPA:IVA) | Finanzwire

Basculer en Français

11018	Companies
241417	Keywords
169938	Articles
129972	Press releases

Home
Companies
INVENTIVA

PRESS RELEASE

published on 07/09/2025 at 22:05, 1 year 2 months ago

Inventiva names Jason Campagna as President of R&D and Chief Medical Officer and Martine Zimmermann as Executive Vice President of Regulatory Affairs and Quality Assurance
Inventiva appoints Jason Campagna as President of R&D and CMO and Martine Zimmermann as EVP of Regulatory Affairs and Quality Assurance, emphasizing long-term growth and operational excellence

Quality Assurance R&D Leadership Appointments Regulatory Affairs Inventiva
BRIEF

published on 07/07/2025 at 22:05, 1 year 2 months ago

Inventiva Receives $10 Million Milestone Payment from CTTQ

Milestone Payment Lanifibranor Biopharmaceutical Development MASH Treatment CTTQ Partnership
PRESS RELEASE

published on 07/07/2025 at 22:00, 1 year 2 months ago

Inventiva receives $10 million milestone payment from CTTQ
Inventiva receives $10 million milestone payment from CTTQ following successful structured financing. Partnership aims to develop lanifibranor for MASH treatment in Chinese regions

Inventiva Milestone Payment MASH Lanifibranor CTTQ
BRIEF

published on 07/02/2025 at 22:05, 1 year 2 months ago

Inventiva Publishes Promising Results on Lanifibranor for Liver Disease

Phase 2b Study Liver Disease Lanifibranor MASH Treatment Journal Of Hepatology Reports
PRESS RELEASE

published on 07/02/2025 at 22:00, 1 year 2 months ago

Inventiva announces the publication in Journal of Hepatology Reports on results of lanifibranor treatment on liver sinusoidal endothelial cells in patients with MASLD/MASH and in preclinical models of the disease
Inventiva announces publication in Journal of Hepatology Reports on lanifibranor treatment effects on liver sinusoidal endothelial cells in MASLD/MASH patients and preclinical models, showing potential therapeutic benefits

Inventiva MASH Lanifibranor Journal Of Hepatology Reports LSEC Capillarization
BRIEF

published on 06/10/2025 at 22:05, 1 year 3 months ago

Renée Aguiar-Lucander Joins Inventiva's Board of Directors

Board Of Directors Biopharmaceutical Inventiva Lanifibranor Renée Aguiar-Lucander
PRESS RELEASE

published on 06/10/2025 at 22:00, 1 year 3 months ago

Inventiva Announces the Appointment of Renée Aguiar-Lucander to its Board of Directors
Inventiva appoints Renée Aguiar-Lucander to its Board of Directors. Aguiar-Lucander brings extensive industry experience and leadership to the company

Board Of Directors Biopharmaceutical Inventiva Lanifibranor Renée Aguiar-Lucander
BRIEF

published on 05/27/2025 at 22:05, 1 year 3 months ago

Inventiva at the Jefferies and UBS Healthcare Conferences

Biopharmaceuticals Inventiva MASH UBS Conference Jefferies Conference
PRESS RELEASE

published on 05/27/2025 at 22:00, 1 year 3 months ago

Inventiva to Participate in the Upcoming Jefferies Global Healthcare Conference and UBS Spring Biotech Conference
Inventiva to participate in Jefferies Global Healthcare Conference & UBS Spring Biotech Conference. CEO to present at fireside chat in New York City

Clinical-stage Biopharmaceutical Company Inventiva Jefferies Global Healthcare Conference Lanifibranor UBS Spring Biotech Conference
BRIEF

published on 05/23/2025 at 08:35, 1 year 3 months ago

Inventiva Reports First Quarter 2025 Financials: Cash Position Declines

Financial Results Cash Position Clinical Trial Inventiva Lanifibranor

Accesswire

Published on 09/18/2026 at 04:25, 42 minutes ago

Empress Announces Resumption of Trading
Published on 09/18/2026 at 00:55, 4 hours 12 minutes ago

Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 00:25, 4 hours 42 minutes ago

CoTec Holdings Corp. Announces Initial Closing of Private Placement of Unsecured Convertible Debentures
Published on 09/17/2026 at 22:15, 6 hours 52 minutes ago

Rocky Shore Gold Announces Non-Brokered Private Placement
Published on 09/17/2026 at 22:15, 6 hours 52 minutes ago

Vanta Attends 2026 All-In Summit in Los Angeles, a Leading Gathering of Business, Investment and Industry Leaders

View all ACCESSWIRE

EQS Group

Published on 09/17/2026 at 19:00, 10 hours 6 minutes ago

Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 18:58, 10 hours 8 minutes ago

EQS-Adhoc: H2APEX Group SCA: General Partner of H2APEX Group SCA resolves to prepare for the transfer of its stock exchange listing from the Regulated Market (Prime Standard) to the Scale segment of the Frankfur
Published on 09/17/2026 at 18:25, 10 hours 41 minutes ago

Magentic raises $18M to build the AI workforce for the physical world
Published on 09/17/2026 at 18:10, 10 hours 56 minutes ago

A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
Published on 09/17/2026 at 17:46, 11 hours 20 minutes ago

RBI categorically denies the allegations of short-seller report

Les Echos

Published on 09/17/2026 at 17:40, 11 hours 27 minutes ago

Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 20:46, 1 day 8 hours ago

LNA SANTE : 2026 First Half Results
Published on 09/16/2026 at 17:45, 1 day 11 hours ago

5th edition of “On the way up” show
Published on 09/16/2026 at 17:45, 1 day 11 hours ago

Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 22 hours ago

bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification

View all LES ECHOS COMFI WIRE